Pharmafile Logo
Pharmafocus logo
Advanced Search

Illumina

Showing 13 posts of 13 posts found.

c_agsandrew_-_fotolia

Philips and Illumina partner up for integrated genomics oncology solution

January 11, 2017
Research and Development Illumina, Philips, oncology

Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …

News

Illumina shares plunge as it cuts Q1 outlook

April 20, 2016
Research and Development, Sales and Marketing Financial, Illumina, Share price, Shares, outlook, revenue, stock market

Shares in Illumina (Nasdaq: ILMN) plunged after the company cut its revenue estimates for the first quarter based on low …

News
Illumina building

Illumina forms spin-off to develop cancer detection test

January 14, 2016
Research and Development Cancer, Illumina, cancer detection, gene sequencing, liquid biospy, oncology

Global gene sequencing company Illumina has won over $100 million in investment from high-profile investors, to create a company “to …

News
Merck Serono image

Merck Serono bets on precision medicine

March 11, 2015
Sales and Marketing AstraZeneca, Diagnostics, FDA, Illumina, Merck Serono, opexa, personalised

Merck Serono is looking to expand further into personalised medicine as the company enters into an agreement with Illumina to …

News
Genentech image

Genentech and Human Longevity ink genomics deal

January 19, 2015
Research and Development, Sales and Marketing 23andME, DNA, Genentech, Illumina, hli, human longevity

Genentech is partnering with US genetics firm Human Longevity (HLI) in another 2015 genomics deal to continue its push into …

News
astrazeneca_sign_sky_14

AstraZeneca and Illumina in new partnership

August 26, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Illumina, NGS technology, next generation sequencing

AstraZeneca has announced that it will develop next generation sequencing (NGS) for companion diagnostic tests in a new partnership with …

News
roche_glass_building

Roche pays $8.3bn for InterMune

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche

Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …

News
david_cameron_3

Genomes Project gains £300m UK funding boost

August 1, 2014
Medical Communications, Research and Development, Sales and Marketing Genomics england, Illumina, NHS England, david cameron, genomes

A new funding stream aimed at helping British scientists map human DNA code will ‘revolutionise medicine’, according to prime minister …

News
Roche image

Roche earmarks $300m for diagnostics HQ

June 26, 2012
Manufacturing and Production Diagnostics, Illumina, Roche, US, manufacturing

Roche has said it intends to invest $300 million over the next 10 years at its diagnostics headquarters in Indianapolis, …

News
Severin Schwann

Roche abandons Illumina takeover bid

April 19, 2012
Sales and Marketing Diagnostics, Illumina, Roche, mergers and acquisitions

Roche has conceded defeat in its bid to buy Illumina, after shareholders of the diagnostics firm blocked the takeover – …

News
Roche

Roche on target despite European shrinkage

April 12, 2012
Sales and Marketing Illumina, Q1 2012, Roche

Roche saw its business grow in the first three months of the year, thanks to strong showings from hepatitis C …

News
Roche picture

Roche launches $5.7 billion hostile bid for Illumina

January 25, 2012
Research and Development, Sales and Marketing Diagnostics, Illumina, Roche

Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …

News

The utility of next generation sequencing in drug development

November 3, 2010
Research and Development Dr Cheng Eng Ang, Illumina, Source BioScience, drug development, genomics, human genome, next generation sequencing

Drug development studies are extremely expensive, costing many millions of pounds and taking up to 12 years to bring a …

Feature

Latest content

FDA grants marketing authorisation to DNA test for predisposition to certain cancers

October 2, 2023

Biogen’s biosimilar Tofidence approved by FDA

October 2, 2023

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023

Karuna Therapeutics submits NDA to FDA for schizophrenia treatment

September 29, 2023

Kura Oncology shares preclinical data for NSCLC treatment

September 29, 2023